STADA: CapVest Completes Majority Acquisition Of Global Pharmaceuticals Company - Pulse 2.0
CapVest→STADA Arzneimittel
Apr 1, 2026
Danaher has acquired Masimo, a medical devices business in California, for over $100M. Masimo develops noninvasive patient monitoring technologies used in hospitals and care settings, supporting oxygenation and vital-sign measurement workflows. Danaher acquisitions in healthcare M&A expand its medical devices portfolio and strengthen capabilities in patient monitoring, aligning with strategic acquisition priorities in CA acquisitions. The merger acquisition is structured as a strategic acquisition by Danaher, with the Masimo acquisition announced in February 2026 under an execution version agreement and plan of merger.
CapVest→STADA Arzneimittel
Apr 1, 2026
Lilly→Centessa Pharmaceuticals
Mar 31, 2026
Jimini Health
Mar 31, 2026
Eris Lifesciences→Velbiom Probiotics
Mar 31, 2026
Biogen→Apellis Pharmaceuticals
Mar 31, 2026